In these tumor-promoting contexts, EphA2 activation relies on the so-called non-canonical EphA2 pathway, which is characterized by phosphorylation at serine 897 by pro-tumorigenic kinases, such as PKA, RSK kinases and Akt [14,15,16]. The gene discussed is EPHA2; the disease is neoplasm.